Prognostic value of cathepsin D expression and association with histomorphological subtypes in breast cancer
- PMID: 9683294
- PMCID: PMC2062888
- DOI: 10.1038/bjc.1998.465
Prognostic value of cathepsin D expression and association with histomorphological subtypes in breast cancer
Abstract
This study investigated the prognostic value of immunohistochemically detected cathepsin D expression in 103 invasive ductal carcinomas of the breast at stages pT1 and 2. We also assessed the association between cathepsin D expression and histomorphological tumour subtypes (invasive ductal carcinoma with extensive intraductal component, multifocal tumour). Cathepsin D expression was examined at two cut-off levels (positive and highly positive) and separately identified within the epithelial and stromal component of all tumours. Positive and highly positive epithelial expression was detected in 32 (31.1%) and 20 (19.4%) patients respectively. Stromal expression was found in 35 (34%) and 19 (18.4%) cases respectively. Epithelial cathepsin D expression was associated with stage and nuclear grade, but not with lymph node or oestrogen receptor status. Positive and highly positive epithelial cathepsin D expression showed significant prognostic value for overall survival (P = 0.003 and 0.01) and recurrence-free interval (P = 0.04 and 0.02). Cathepsin D expression in stromal cells was not associated with either several established prognostic factors or survival. Multivariate analysis revealed that cathepsin D expression failed to be an independent predictor of patients' outcome. Cathepsin D expression shows no significant association with histomorphological subtypes of breast cancer. Our study supports the prognostic impact of immunohistochemically detected cathepsin D expression in the epithelial component of breast cancer.
Similar articles
-
Prognostic significance of cathepsin-D expression in node-positive breast carcinoma: an immunohistochemical study.Int J Cancer. 1993 Sep 30;55(3):429-35. doi: 10.1002/ijc.2910550318. Int J Cancer. 1993. PMID: 8397164
-
Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients.Br J Cancer. 1999 Jan;79(2):300-7. doi: 10.1038/sj.bjc.6690048. Br J Cancer. 1999. PMID: 9888472 Free PMC article.
-
Cathepsin D in primary breast carcinoma: adverse prognosis is associated with expression of cathepsin D in stromal cells.Breast Cancer Res Treat. 1995;33(2):137-45. doi: 10.1007/BF00682721. Breast Cancer Res Treat. 1995. PMID: 7749141
-
Significance of the tumor protease cathepsin D for the biology of breast cancer.Histol Histopathol. 2014 Apr;29(4):433-8. doi: 10.14670/HH-29.10.433. Epub 2013 Nov 22. Histol Histopathol. 2014. PMID: 24265119 Review.
-
Cathepsin D in breast cancer: mechanisms and clinical applications, a 1999 overview.Clin Chim Acta. 2000 Feb 15;291(2):157-70. doi: 10.1016/s0009-8981(99)00226-0. Clin Chim Acta. 2000. PMID: 10675721 Review.
Cited by
-
Cathepsin D deficiency in mammary epithelium transiently stalls breast cancer by interference with mTORC1 signaling.Nat Commun. 2020 Oct 12;11(1):5133. doi: 10.1038/s41467-020-18935-2. Nat Commun. 2020. PMID: 33046706 Free PMC article.
-
Determination of c-myc amplification and overexpression in breast cancer patients: evaluation of its prognostic value against c-erbB-2, cathepsin-D and clinicopathological characteristics using univariate and multivariate analysis.Br J Cancer. 1999 Dec;81(8):1385-91. doi: 10.1038/sj.bjc.6693404. Br J Cancer. 1999. PMID: 10604737 Free PMC article.
-
Correlation between cathepsin D expression and p53 protein nuclear accumulation in oesophageal squamous cell carcinoma.J Clin Pathol. 2002 Feb;55(2):121-6. doi: 10.1136/jcp.55.2.121. J Clin Pathol. 2002. PMID: 11865007 Free PMC article.
-
Cathepsins B, D, and G Are Expressed in Metastatic Head and Neck Cutaneous Squamous Cell Carcinoma.Front Oncol. 2021 Sep 21;11:690460. doi: 10.3389/fonc.2021.690460. eCollection 2021. Front Oncol. 2021. PMID: 34621666 Free PMC article.
-
To handle the inflation of odds ratios in a retrospective study with a profile penalized log-likelihood approach.J Clin Lab Anal. 2021 Jul;35(7):e23849. doi: 10.1002/jcla.23849. Epub 2021 May 27. J Clin Lab Anal. 2021. PMID: 34043251 Free PMC article. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical